Polyamines induce resistance to cationic peptide, aminoglycoside, and quinolone antibiotics in Pseudomonas aeruginosa PAO1.

Antimicrobial Agents and Chemotherapy
Dong H Kwon, Chung-Dar Lu

Abstract

Pseudomonas aeruginosa, a gram-negative bacterium of human pathogens, is noted for its environmental versatility, enormous metabolic capacity, and resistance to antibiotics. Overexpression of the outer membrane protein OprH and increased resistance to polycationic peptide antibiotics (e.g., polymyxin B) mediated by the PhoPQ two-component system on induction of a putative lipopolysaccharide (LPS) modification operon (PA3552-PA3559) have been reported as part of the adaptive responses to magnesium limitation in P. aeruginosa. Induction of the oprH-phoPQ operon and the LPS modification operon by exogenous spermidine was revealed from GeneChip analysis during studies of polyamine metabolism and was confirmed by the lacZ fusions of affected promoters. From the results of MIC measurements, it was found that addition of spermidine or other polyamines to the growth medium increased the MIC values of multiple antibiotics, including polycationic antibiotics, aminoglycosides, quinolones, and fluorescent dyes. MIC values of these compounds in the transposon insertion mutants of oprH, phoP, phoQ, and pmrB were also determined in the presence and absence of spermidine. The results showed that the spermidine effect on cationic peptide antibi...Continue Reading

References

Jul 7, 1977·Molecular & General Genetics : MGG·D HaasT Leisinger
Mar 1, 1985·Microbiological Reviews·H Nikaido, M Vaara
Oct 1, 1989·Journal of Bacteriology·C D LuA Abdelal
Jul 1, 1996·Journal of Bacteriology·A L Dela Vega, A H Delcour
May 18, 2000·Biochemical and Biophysical Research Communications·K Igarashi, K Kashiwagi
Aug 11, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Robert E. W. Hancock, David P. Speert
Feb 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David M Livermore
Jan 10, 2003·Molecular Microbiology·Chakib Mouslim, Eduardo A Groisman
Nov 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michael A JacobsColin Manoil
May 20, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·A Gugliucci
Jun 4, 2004·Journal of Bacteriology·Chung-Dar LuWei Li
Aug 25, 2004·The Journal of Biological Chemistry·Madoka YoshidaKazuei Igarashi

❮ Previous
Next ❯

Citations

Dec 5, 2012·World Journal of Microbiology & Biotechnology·Hamouda ElabedKamel Gaddour
Aug 3, 2013·Systematic and Applied Microbiology·Alexander FosterMark A Keane
May 24, 2012·The Journal of Antimicrobial Chemotherapy·Keith Poole
Nov 13, 2012·Nucleic Acids Research·Deepak BalasubramanianKalai Mathee
May 14, 2008·Antimicrobial Agents and Chemotherapy·Ulysses W Sallum, Thomas T Chen
Feb 16, 2011·Antimicrobial Agents and Chemotherapy·Agatha N JassemDavid P Speert
Apr 18, 2007·Antimicrobial Agents and Chemotherapy·Dong-Hyeon Kwon, Chung-Dar Lu
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Jerrylynn ManuelTeresa de Kievit
Feb 1, 2012·Antimicrobial Agents and Chemotherapy·Simone Maria-NetoOctávio Luiz Franco
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·Dong H Kwon, Chung-Dar Lu
Jan 15, 2008·Journal of Bacteriology·Han Ting ChouChung-Dar Lu
Aug 13, 2013·Current Microbiology·Chun-Kai YangChung-Dar Lu
Aug 7, 2012·Expert Opinion on Drug Discovery·Omar M El-Halfawy, Miguel A Valvano
Feb 16, 2016·MedChemComm·Sylvie Garneau-Tsodikova, Kristin J Labby
Apr 2, 2013·Enzyme and Microbial Technology·Alexander FosterMark A Keane
Feb 4, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Lucía FernándezRobert E W Hancock
Mar 10, 2016·BMC Biochemistry·Andreas KrämerFranz-Josef Meyer-Almes
Mar 12, 2016·Journal of Medicinal Chemistry·Bo WangPatrick M Woster
Feb 27, 2009·FEMS Microbiology Reviews·W James Gooderham, Robert E W Hancock
May 27, 2016·Future Medicinal Chemistry·Marine BlanchetJean Michel Brunel
Apr 30, 2016·Journal of Biomolecular Structure & Dynamics·Jyoti Singh Tomar, Rama Krishna Peddinti
Nov 1, 2012·ACS Chemical Biology·Bernd Becker, Matthew A Cooper
May 29, 2015·Molecular & Cellular Proteomics : MCP·Xia WuJames E Bruce
Jul 26, 2017·Critical Reviews in Microbiology·Charlotte VolgersFrank R M Stassen
Apr 11, 2018·Antimicrobial Agents and Chemotherapy·Mei-Ling HanJian Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.